Background: Primary percutaneous coronary intervention (pPCI) performed for STEMI may be complicated by the “no-reflow” phenomenon. Aims: A super-selective intracoronary injection of saline solution through a thrombus aspiration catheter (SALINE technique), was investigated for the treatment of no-reflow as compared with the standard care of therapy (SCT). Methods: Among the 1471 patients with STEMI undergoing pPCI between May 2015 and June 2020, 168 patients developed no-reflow. Primary endpoints were the incidence of ST-segment resolution (STR) ≥ 70% at 90 min after PCI and the rate of flow restoration (TIMI flow grade 3 with an MBG > 1). The secondary endpoint was the incidence of major adverse cardiac and cerebrovascular events at 3 years follow-up. Results: After propensity score matching analysis, patients treated with SALINE showed STR ≥ 70% in twelve out of the sixteen patients (75.0%), compared to only three patients out of the sixteen in the SCT control group (19.0%), (p < 0.004). SALINE was associated with a higher probability of final TIMI flow grade 3 with an MBG > 1, as shown in fourteen out of sixteen patients (87.5%), as compared to only seven out of sixteen patients in the SCT group (43.8%), (p < 0.03). MACCE at 3 years follow-up occurred in only one patient (6.3%) in the SALINE group, as compared to eight patients (50%) in the SCT group (p = 0.047). Conclusions: The SALINE technique showed to be a safe and effective strategy to reduce “no-reflow” in STEMI patients as assessed by significant STR, improvement of TIMI flow grade, and better 3-year outcomes.
1 October 2025 in Minerva Cardiology and Angiology
Acute coronary syndromes (ACS) are frequently the first manifestation of cardiovascular disease and require timely intervention. Primary percutaneous coronary intervention (pPCI) significantly reduces mortality and major adverse cardiovascular events in patients with ST-elevation myocardial infarction (STEMI). However, despite successful epicardial recanalization, pPCI can be complicated by inadequate myocardial reperfusion, a phenomenon known as coronary no-reflow (NR) or microvascular obstruction (MVO), which is associated with adverse outcomes. The aim is to describe a novel interventional approach - the saline technique - for the treatment of MVO following stent implantation during pPCI. The saline technique consists of a rapid, manual intracoronary injection of 10 mL of saline over 2-4 seconds using a 6-Fr thrombus aspiration catheter positioned distally to the stented segment. The aim is to rapidly increase distal coronary pressure and volume, promoting microvascular recruitment and displacement of micro-emboli and vasoconstrictive agents. A diagnostic step using distal angiography precedes treatment to confirm MVO. Preliminary data from a single-center matched cohort (N.=32) showed that the Saline Technique significantly improved TIMI flow grade and ST-segment resolution compared to standard care. No major complications were observed. Post-procedural Index of Microvascular Resistance (IMR) was reduced in most cases. The saline technique is a safe, cost-effective, and rapidly deployable option for managing coronary NR/MVO. While promising, these findings are hypothesis-generating and require confirmation in larger, randomized trials.